Compelling Benefit of Soluble Suppression of Tumorigenicity‐2 in Post–Myocardial Infarction Estimation of Risk: The Time Is Right for Its Routine Use in the Clinic
| 出版年: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
|---|---|
| 主要な著者: | , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Wiley
2017-10-01
|
| 主題: | |
| オンライン･アクセス: | https://www.ahajournals.org/doi/10.1161/JAHA.117.007665 |
| ISSN: | 2047-9980 |
|---|